Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lia M Haynes

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Visualized Experiments : Jove|February 22, 2013
Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitroJennifer L Harcourt, Lia M Haynes
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2016
RSV Growth and Quantification by Microtitration and qRT-PCR AssaysHayat Caidi, Jennifer L Harcourt, Lia M Haynes
Journal of Virology|June 20, 2002
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infectionLia M Haynes, Joelyn Tonkin, Larry J Anderson, et al.
Journal of Virological Methods|April 5, 2011
Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infectionJennifer L Harcourt, Hayat Caidi, Larry J Anderson, et al.
Immunotherapy|September 30, 2010
Therapeutic targeting of respiratory syncytial virus G-proteinLawrence M Kauvar, Jennifer L Harcourt, Lia M Haynes, et al.
Journal of Virology|August 28, 2003
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PLia M Haynes, Les P Jones, Albert Barskey, et al.
BMC Research Notes|January 7, 2016
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cellsJennifer L Harcourt, Melissa McDonald, Pavel Svoboda, et al.
Plos One|January 10, 2013
Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c miceHayat Caidi, Jennifer L Harcourt, Ralph A Tripp, et al.
Journal of Virological Methods|August 2, 2011
Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43Elisabeth G Blanchard, Congrong Miao, Thomas E Haupt, et al.
Vaccines|July 4, 2017
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to InfectionAbhijeet A Bakre, Jennifer L Harcourt, Lia M Haynes, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Visualized Experiments : Jove|February 22, 2013
Establishing a liquid-covered culture of polarized human airway epithelial Calu-3 cells to study host cell response to respiratory pathogens in vitroJennifer L Harcourt, Lia M Haynes
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2016
RSV Growth and Quantification by Microtitration and qRT-PCR AssaysHayat Caidi, Jennifer L Harcourt, Lia M Haynes
Journal of Virology|June 20, 2002
Neutralizing anti-F glycoprotein and anti-substance P antibody treatment effectively reduces infection and inflammation associated with respiratory syncytial virus infectionLia M Haynes, Joelyn Tonkin, Larry J Anderson, et al.
Journal of Virological Methods|April 5, 2011
Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infectionJennifer L Harcourt, Hayat Caidi, Larry J Anderson, et al.
Immunotherapy|September 30, 2010
Therapeutic targeting of respiratory syncytial virus G-proteinLawrence M Kauvar, Jennifer L Harcourt, Lia M Haynes, et al.
Journal of Virology|August 28, 2003
Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance PLia M Haynes, Les P Jones, Albert Barskey, et al.
BMC Research Notes|January 7, 2016
Human cathelicidin, LL-37, inhibits respiratory syncytial virus infection in polarized airway epithelial cellsJennifer L Harcourt, Melissa McDonald, Pavel Svoboda, et al.
Plos One|January 10, 2013
Combination therapy using monoclonal antibodies against respiratory syncytial virus (RSV) G glycoprotein protects from RSV disease in BALB/c miceHayat Caidi, Jennifer L Harcourt, Ralph A Tripp, et al.
Journal of Virological Methods|August 2, 2011
Development of a recombinant truncated nucleocapsid protein based immunoassay for detection of antibodies against human coronavirus OC43Elisabeth G Blanchard, Congrong Miao, Thomas E Haupt, et al.
Vaccines|July 4, 2017
The Central Conserved Region (CCR) of Respiratory Syncytial Virus (RSV) G Protein Modulates Host miRNA Expression and Alters the Cellular Response to InfectionAbhijeet A Bakre, Jennifer L Harcourt, Lia M Haynes, et al.
Pageof 5